Article Details
Retrieved on: 2021-06-14 00:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... has shown synergistic effects with both proteasome inhibitors and CD38-targeting monoclonal antibodies, both in preclinical and clinical study.
Article found on: www.cancertherapyadvisor.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here